The EMEA cardiac arrest treatment market reached approximately US$1,261 million in 2024 and is projected to grow to roughly US$2,335 million by 2033, at a CAGR of around 7.3%. Market drivers include rising cardiovascular disease prevalence, ageing populations in Europe & MENA region, and increasing deployment of AEDs, ICDs, CPR devices, and emergency therapies. https://www.datamintelligence.com/research-report/emea-cardiac-arrest-treatment-market